Skip to main content
CODX
NASDAQ Industrial Applications And Services

Co-Diagnostics Secures $3.0M Private Placement at Deep Discount Amid Going Concern

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$2.83
Mkt Cap
$8.61M
52W Low
$1.26
52W High
$46.5
Market data snapshot near publication time

summarizeSummary

Co-Diagnostics announced a $3.0 million private placement at a deep discount, issuing shares and warrants, which is critical for its liquidity given a 'going concern' warning but highly dilutive for existing shareholders.


check_boxKey Events

  • $3.0 Million Private Placement Secured

    Co-Diagnostics entered into a private placement to raise $3.0 million in gross proceeds, expected to close on May 21, 2026.

  • Highly Dilutive Offering

    The placement includes 54,915 shares of common stock, 1,592,532 pre-funded warrants, and 3,294,894 common warrants, representing substantial potential dilution for existing shareholders.

  • Deeply Discounted Pricing

    The combined effective offering price is $1.821 per unit, a significant discount to the current market price of $2.83. Common warrants are exercisable at $1.571 per share.

  • Addresses Going Concern Warning

    Proceeds are for general corporate purposes and working capital, providing crucial liquidity for the company which recently reported a 'going concern' warning and significant cash burn.


auto_awesomeAnalysis

Co-Diagnostics has entered into a private placement to raise $3.0 million in gross proceeds, a critical move given its recent 'going concern' warning and significant cash burn. The offering is highly dilutive, involving the issuance of 54,915 shares of common stock, 1,592,532 pre-funded warrants, and 3,294,894 common warrants. The combined effective offering price of $1.821 per unit (share/pre-funded warrant plus common warrant) is a deep discount compared to the current stock price of $2.83, with common warrants exercisable at $1.571. While necessary to extend the company's financial runway, the terms are significantly unfavorable to existing shareholders due to the substantial dilution and discounted pricing. Officers and directors have agreed to a 60-day lock-up, and the company has placed restrictions on future equity issuances for 60-90 days, with an exception for existing ATM programs.

At the time of this filing, CODX was trading at $2.83 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.6M. The 52-week trading range was $1.26 to $46.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CODX - Latest Insights

CODX
May 21, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
CODX
May 19, 2026, 10:54 PM EDT
Source: PR Newswire
Importance Score:
9
CODX
May 14, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
CODX
May 14, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
CODX
May 12, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
9
CODX
May 12, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
9
CODX
May 08, 2026, 9:03 AM EDT
Source: Reuters
Importance Score:
7
CODX
Apr 02, 2026, 9:42 AM EDT
Source: Reuters
Importance Score:
7
CODX
Mar 31, 2026, 4:10 PM EDT
Filing Type: 10-K
Importance Score:
9
CODX
Mar 31, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
10